Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B01ae626b37c83910c1ca42ec06634350> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B01ae626b37c83910c1ca42ec06634350 NCIT_P378 "NCI" @default.
- B01ae626b37c83910c1ca42ec06634350 type Axiom @default.
- B01ae626b37c83910c1ca42ec06634350 annotatedProperty IAO_0000115 @default.
- B01ae626b37c83910c1ca42ec06634350 annotatedSource NCIT_C200045 @default.
- B01ae626b37c83910c1ca42ec06634350 annotatedTarget "An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated antigen (TAA) carcinoembryonic antigen (CEA; carcinoembryonic antigen-related cell adhesion molecule 5; CEACAM5) and the immune checkpoint regulator carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6; CEACAM-6; CD66c) and conjugated to the microtubule-disrupting cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic and immune checkpoint inhibitory activities. Upon administration of anti-CEA/CEACAM6 ADC EBC-129, the monoclonal antibody moiety targets and binds to a specific glycosylation site that is conserved on both CEA and CEACAM6 expressed on tumor cells. Upon binding and internalization, MMAE is released where it targets and binds to tubulin and inhibits microtubule polymerization. This results in G2/M phase cell cycle arrest and apoptosis in CEA and/or CEACAM6-expressing tumor cells. CEA, a member of the CEA family of proteins that plays a key role in cell migration, cell invasion, and cell adhesion, is overexpressed by a variety of cancer cell types. CEACAM6, an immune checkpoint receptor, is associated with tumor-mediated immune suppression. Elevated CEACAM6 expression is associated with advanced tumor stages and poor prognosis." @default.